Chargement en cours...
Novel anti-myeloma immunotherapies targeting the SLAM family of receptors
Treatment for multiple myeloma (MM) has significantly advanced in the last decade with the introduction of proteasome inhibitors and immunomodulatory therapies. Unfortunately, MM continues to cause significant morbidity and most patients eventually succumb to the disease. As in other areas of cancer...
Enregistré dans:
| Publié dans: | Oncoimmunology |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5468000/ https://ncbi.nlm.nih.gov/pubmed/28638731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1308618 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|